je.st
news
OncoSec Medical Selected to Present Phase II Data in Poster...
2014-04-22 15:09:35| Logistics - Topix.net
OncoSec Medical Inc. , a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, will present an update of data from their Phase 2 melanoma study at the American Society of Clinical Oncology's 50th Annual Meeting, taking place May 30-June 3, 2014, at McCormick Place in Chicago, Illinois.
Tags: data
present
selected
medical
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|